An interventional study of Povidone-iodine 5% solution in Cesarean Section, Surgical Site Infection and Endometritis, sponsored by Mohamed Mousa Mohamed Mousa. Not yet recruiting at 1 site in Egypt. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-20.
Sponsored by Mohamed Mousa Mohamed Mousa · Not applicable, Interventional, and Prevention
This randomized controlled trial aims to evaluate the efficacy of preoperative vaginal cleansing with 5% povidone-iodine in reducing postoperative infectious morbidity among women undergoing cesarean section. The primary outcomes include wound-related complications, while secondary outcomes include postoperative fever, endometritis, wound infection, and white blood cell count.
745 studies on the registry are indexed under Surgical Wound Infection; 151 are open to participants now.
This study's planned enrollment of 600 is above the median of 200 across 581 interventional studies indexed under Surgical Wound Infection.
Browse Surgical Wound Infection studies →This is the only study on the registry with Mohamed Mousa Mohamed Mousa as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
- Women undergoing elective or emergency cesarean section. Received prophylactic antibiotics before surgery
Exclusion Criteria:
Drug: Povidone-iodine 5% solution
Participants will not receive preoperative vaginal cleansing before cesarean section. All other perioperative care, including prophylactic antibiotics and skin preparation, will be provided according to the hospital protocol.
Vaginal cleansing with 5% povidone-iodine for 30 seconds before cesarean section.
Incidence of postoperative wound-related complications Time Frame: Within 8 weeks after cesarean section
Time frame: 8 weeks
Incidence of postoperative wound-related complications
Time frame: Within 8 weeks after cesarean section
Postoperative fever (within 8 weeks) Postoperative WBC count (24 hours) Endometritis (within 8 weeks) Combined wound complications and endometritis
Time frame: 8 weeks
Plan to share: No — self limited
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Povidone-Iodine